SBIR/STTR Research Award
CELL TYPE SPECIFIC INACTIVATION OF CANCER GENES
Award amount
$147,708Program and phase
SBIR · Phase IAward year
1999Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Somagenics, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NWMCAECH9RX7
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Not Available We propose to apply our Power Node Control Center (PNCC) technology to develop a converter for the V22 application that meets the power quality, size, weight and cost requirements. The innovations in our concept are: (1) the use of Multi Functional Programmable Modules (MFPM) which are half bridge leg to perform the power factor correction, boost rectification on the input end, and the buck conversion on the output, (2) the use of Pulse Current Modulation to perform the power factor correction on the input, and (3) the use of plastic coated iron powder composite pot cores to form the chokes required for filtering which reduces the size and the cost of the filters. In Phase 1 of this effort, we propose to develop the concept and conduct bench type test to validate key concepts.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Advanced method for preparing cell-free DNA sequencing libraries
- A novel sshRNA-antimiR combination therapy for accelerating healing of diabetic foot ulcers
- Therapeutic Development of RNAi-based inhibitors against the Hepatitis Delta Virus
- Highly accurate small RNA sequencing of single cells RealSeq SC
- Advanced method for preparing cell free DNA sequencing libraries
Research funding history
39 SBIR/STTR records share this UEI (1994–2020). Reported award amounts total $23,258,381. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services